Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-08-23

Clinical Trial Update: An Exploratory Investigation to Assess Changes in Quality of Life for Individuals With Type 2 Diabetes After Taking a Meal-replacement Shake. [NA]

View source ↗

Summary

A clinical trial evaluating a meal-replacement shake for quality of life in individuals with Type 2 diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Teatis, Inc | Conditions: Diabetes Mellitus, Type 2 | NA | Status: WITHDRAWN